(Q41248830)

28 September 2017

title

Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A404154

29 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

22 April 2023

author name string

G. Schwinn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A404154

29 June 2022

H. Dirks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A404154

29 June 2022

C. McIntosh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A404154

29 June 2022

J. Köbberling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A404154

29 June 2022

language of work or name

English

0 references

publication date

1 April 1977

1 reference

full work available at URL

28 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1977.tb01580.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1977.tb01580.x/fullpdf

22 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

European Journal of Clinical Investigation

22 April 2023

published in

1 reference

28 September 2017

volume

7

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

101-107

1 reference

Bromocriptine therapy in acromegaly

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1977.TB01580.X

Systemic fat embolism following acute primary osteomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1977.TB01580.X

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1977.TB01580.X

Plasma prolactin levels after TRH and chlorpromazine in normal subjects and patients with impaired pituitary function

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate

22 April 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA)

22 April 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Acromegaly treated with chlorpromazine. A case study

22 April 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion

22 April 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Chlorpromazine treatment and growth hormone secretory responses in acromegaly

22 April 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

The Secretion Rate of Human Growth Hormone. II. Acromegaly, Effect of Chlorpromazine Treatment

22 April 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Inhibitory Effect of Dopaminergic Stimulation on GH Release in Acromegaly

22 April 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Suppressibility of Plasma Growth Hormone Levels in Acromegaly with Dexamethasone and Phentolamine1

22 April 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]

22 April 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration

22 April 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses

22 April 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

22 April 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Stable Reduction of Plasma Growth Hormone (hGH) Levels During Chronic Administration of 2-Br-α-ergocryptine (CB-154) in Acromegalic Patients

22 April 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Treatment of acromegaly with bromocryptine

22 April 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

Bromocriptine treatment of acromegaly

22 April 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1977.TB01580.X

22 April 2023

Identifiers

1 reference

28 September 2017

1 reference